17. November 2016

Abstract Most ophthalmic illnesses are treated by topical administration of drug in the form of conventional dosage forms (solutions, suspensions, or ointments). In spite of remarkable patient compliance, these dosage forms suffer from the issues of poor ocular bioavailability due to pathophysiological barriers prevailing in the eye. In recent decades, numerous efforts have been made to advance ophthalmic drug delivery including the one adopted to prolong the residence time of drug in the...